MedTrace Logo

2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.

NCT00592098 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2008-01-11

No results posted yet for this study

Summary

The objective of this study is to investigate the analgesic effect of topical strontium chloride in stump pain, and to prospectively determine other efficacy and safety measures of topical strontium chloride in stump pain.

Conditions

  • Amputation Stumps
  • Pain

Interventions

DRUG

Strontium chloride hexahydrate

Cutaneous solution, 1 ml dose per 100 sq cm of affected skin area, To be applied twice daily for 28 days.

DRUG

Placebo

Cutaneous saline solution, 1 ml dose per 100 sq cm of affected skin area, To be applied twice daily for 28 days.

Sponsors & Collaborators

  • SantoSolve AS

    lead INDUSTRY

Principal Investigators

  • Knut T Smerud, MSc · Smerud Medical Research International AS, Drammensveien 41, N-0271 Oslo, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00592098 on ClinicalTrials.gov